Eris Lifesciences Ltd.
ERIS Share PricePharmaceuticals & Drugs
₹1,710
-1.5 (-0.1%)
As on September 9, 2025
Exchange Scrips: BSE540596NSEERISISININE406M01024
Market Cap ₹ 23,224 Cr
P/E Ratio 66.2
Dividend Yield 0.43 %
Performance
Market performance
Open1,711
High1,729.6
Volumes91,005
Prev1,710
Low1,690.1
As on2025-09-09
Historical performance
1 Year High1,910
3 Year High1,910
5 Year High1,910
1 Year Low1,097.2
3 Year Low551.3
5 Year Low470
Fundamentals
Company Valuation
Market Cap (₹Cr)
23,224
Face Value (₹)
1
P/E Ratio
66.2
Dividend Yield
0.43 %
Investment Returns
1 Year
17%
3 Years
143.5%
5 Years
254.4%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 1,738.82 | Bearish |
| 10-DMA | 1,763.17 | Bearish |
| 20-DMA | 1,747 | Bearish |
| 50-DMA | 1,748.88 | Bearish |
| 100-DMA | 1,655.57 | Bullish |
| 200-DMA | 1,493.12 | Bullish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 5 | 5 | 5 | 5 | 5 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 5 | 5 | 5 | 5 | 5 |
| Public Investors | 52220 | 50082 | 53309 | 46341 | 44171 |
| Government | 1 | 1 | 1 | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 66.2.
- 3Y Stock Price CAGR of the stock is 34.8.
- The stock has a beta of 0.4.
- In the last financial year, the company had an EBITDA of ₹10356 Million.
- The company generated revenue of ₹28936 Million in the previous financial year.
Eris Lifesciences Ltd.
1710-1.5 (-0.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1164295
No. of Shares: 681 (Approx)
Performance:16.4%
P/L: ₹164295
Top Gainers
| Symbol | Change% |
|---|---|
| ITDC | 653.6(20%) |
| LASA | 12.74(20%) |
| PRECAM | 254.93(16%) |
| JTEKTINDIA | 181.94(15%) |
| QUICKHEAL | 335.1(14%) |
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent